The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents
Author:
Affiliation:
1. Campbell Family Institute for Breast Cancer Research, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm400380m
Reference56 articles.
1. Targeted anti-mitotic therapies: can we improve on tubulin agents?
2. Kinesin spindle protein Inhibitors as anticancer agents
3. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
4. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
5. Update on aurora kinase targeted therapeutics in oncology
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. QSAR, molecular docking, and dynamics-based computational discovery of potential PLK4 inhibitors for tumor therapy;Process Biochemistry;2024-11
2. Synthesis and Utilization of 1H-Indazole N-Oxides in the Production of C3-Functionalized 1H-Indazoles;Synthesis;2024-04-30
3. Therapeutic potential of targeting polo-like kinase 4;European Journal of Medicinal Chemistry;2024-02
4. Spirooxindole derivatives as kinase-based anticancer agents;Spirooxindole;2024
5. Is It Possible to Obtain a Product of the Desired Configuration from a Single Knoevenagel Condensation? Isomerization vs. Stereodefined Synthesis;International Journal of Molecular Sciences;2023-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3